KTTA · Pasithea Therapeutics Corp.

$0.57 +0.01 (+1.79%) At close · Aug 26

Market Cap

$19.01M

33.41M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-21	2026-08-20
10-Q	2026-08-14	2026-06-30
DEF 14A	2026-08-07	2026-09-09
10-Q	2026-05-15	2026-03-31
8-K	2026-05-04	2026-05-01
10-K	2026-03-30	2025-12-31
8-K	2026-02-20	—
8-K	2026-01-28	—
DEF 14A	2025-12-29	2026-01-28
8-K	2025-12-15	2025-12-12
8-K	2025-12-02	2025-11-28
8-K	2025-11-25	2025-11-20
10-Q	2025-11-13	2025-09-30
8-K	2025-11-04	—
8-K	2025-10-27	2025-10-24
8-K	2025-09-16	—
8-K	2025-09-03	—
10-Q	2025-08-14	2025-06-30
DEF 14A	2025-07-24	2025-09-03
8-K	2025-07-11	2025-07-10
8-K	2025-06-27	2025-06-23
8-K	2025-06-20	—
10-Q	2025-05-15	2025-03-31
8-K	2025-05-07	2025-05-06
8-K	2025-04-25	2025-04-23
10-K	2025-03-24	2024-12-31
8-K	2024-11-26	—
10-Q	2024-11-13	2024-09-30
8-K	2024-09-30	2024-09-26
8-K	2024-09-26	—
10-Q	2024-08-13	2024-06-30
8-K	2024-06-26	—
DEF 14A	2024-05-28	2024-06-26
8-K	2024-05-14	2024-05-13
10-Q	2024-05-14	2024-03-31
10-K	2024-03-29	2023-12-31
8-K	2024-01-18	2024-01-17
8-K	2024-01-02	2023-12-29
8-K	2023-12-28	—
8-K	2023-12-19	—
10-Q	2023-11-13	2023-09-30
DEF 14A	2023-10-26	2023-11-29
8-K	2023-10-13	2023-10-06
8-K	2023-09-14	—
10-Q	2023-08-11	2023-06-30
8-K	2023-07-20	2023-07-19
8-K	2023-07-20	—
10-Q	2023-05-12	2023-03-31
10-K/A	2023-04-04	2022-12-31
10-K	2023-03-30	2022-12-31

Showing 1–50 of 70 filings

Key facts CIK 1841330 CUSIP 70261F202 13F (30d) 32 filings 31 filers Visit website Investor relations